hypertension evaluation 2
TRANSCRIPT
![Page 1: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/1.jpg)
HYPERTENSION
Evaluation of Hypertension - 2
Mohammad Ilyas, M.D.
Assistant Clinical Professor
University of Florida / Health Sciences Center
Jacksonville, Florida USA 1
![Page 2: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/2.jpg)
Outline
1. Definition, Regulation and Pathophysiology
2. Measurement of Blood Pressure, Staging of Hypertension and Ambulatory Blood Pressure Monitoring
3. Evaluation of Primary Versus Secondary
4. Sequel of Hypertension and Hypertension Emergencies
5. Management of Hypertension (Non-Pharmacology versus Drug Therapy)
6. The Relation Between Hypertension: Obesity, Drugs, Stress and Sleep Disorders.
7. Hypertension in Renal diseases and Pregnancies
8. Pediatric, Neonatal and Genetic Hypertension
2
![Page 3: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/3.jpg)
Types of Hypertension
• Primary HTN:
• >95% cases of HTN in adult
• Cause Unknown.
• Multiple risk factors: including age,
family history, genetics, race,
environment etc…
• Secondary HTN:
• < 5% HTN in adult are secondary
• Secondary to other potentially
rectifiable causes.
• Often overlooked & under screen
3
![Page 4: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/4.jpg)
Secondary HTN
Overview
• Testing for secondary HTN can be expensive and requires high
index of clinical suspicion.
• General principles:
• New onset HTN if <30 or >50 years of age
• HTN refractory to medical Rx (>3-4 meds)
• Specific clinical/lab features typical for dz :
4
![Page 5: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/5.jpg)
Causes of Secondary HTN
• Common
1. Intrinsic renal disease
2. Renovascular disease
3. Mineralocorticoid excess
4. Sleep Breathing disorder
• Uncommon
1. Pheochromocytoma
2. Glucocorticoid excess
3. Coarctation of Aorta
4. Hyper/hypothyroidism
5
![Page 6: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/6.jpg)
1. Renal Parenchymal Disease
• Common cause of secondary HTN (2-5%)
• HTN is both cause and consequence of renal disease
• Multifactorial cause for HTN including disturbances in Na/water balance, vasodepressors/ prostaglandins imbalance
• Renal disease from multiple etiologies.
6
![Page 7: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/7.jpg)
2. Renovascular HTN
•Incidence 1-3%
•Etiology
•Atherosclerosis 75-90% (elder)
•Fibromuscular dysplasia 10-25%
(younger)
•Other
•Aortic/renal dissection
•Takayasu’s arteritis
•Thrombotic/cholesterol emboli
•CVD
•Post transplantation stenosis
•Post radiation
7
![Page 8: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/8.jpg)
Renovascular HTN – History
• History
• Onset HTN age <30 or >55
• Negative FH of HTN
• Sudden onset uncontrolled HTN in previously well controlled patient
• Accelerated/malignant HTN
• Intermittent pulmonary edema with normal LV function
8
![Page 9: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/9.jpg)
Renovascular HTN - Clinical
• Clinical exam. /Lab. findings
• Epigastric bruit, particularly systolic/diastolic
• Advanced fundal changes, grade III/IV retinopathy
• Azotemia induced by ACEI, ARBs or diuretics
• Paradoxical worsening of HTN with diuretics
• Secondary aldosteronism : ↑ plasma renin & ↓ s. Na & K
• Unilateral small kidney, difference >1.5cm, on sonography 9
![Page 10: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/10.jpg)
Renovascular HTN – Diagnostic studies
• Physical findings (bruit)
• Duplex U/S
• Captopril renography
• Magnetic Resonance Angiography
• Renal Angiography
10
![Page 11: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/11.jpg)
Fibromuscular dysplasia Atherosclerotic RAS
• Fibromuscular dysplasia
• 10-25% of all RAS
• Young female, age 15-40
• Medial disease 90%, often
involves distal RA
• Atherosclerotic RAS
• 75-90% of RAS
• Usually men, age >55,
• Other atherosclerotic
11
![Page 12: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/12.jpg)
RAS screening/diagnostics
Sens Spec Limitation
Bruit 39-65% 90-99% Insensitive, severe stenosis may be silent
Duplex U/S 90-95% 60-90%
Operator dependent, 10-20%
Captopril
Renography 83-91% 87-93%
Accuracy reduced in pt with renal insufficiency,
lacks anatomical info; good predictor of BP
response
MRA 88-95% 95% False positive artifact resp, peristalsis, tortuous
vessels; cost
Angiography Gold std Gold std Invasive, nephrotoxicity, little value in
predicting BP response
12
![Page 13: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/13.jpg)
Fibromuscular Dysplasia, before and after PTRA Atherosclerotic RAS before and after stent
13
![Page 14: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/14.jpg)
3. Primary Aldosteronism
• Primary Aldosteronism, previously felt to be an unlikely cause of secondary
HTP, now is more commonly observed depending on the severity of HTP :
• 8% Stage 2
• 13% of Stage 3 and
• 20% of those with resistant hypertension.
(10th Annual SMA-ASH Carolinas Georgia Chapter Meeting, 2006)
14
![Page 15: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/15.jpg)
Primary Aldosteronism
• Prevalence 0.5- 2.0% (5-12% in referral centers)
• Etiology
• Adrenal adenoma
• Bilateral adrenal hyperplasia, glucocorticoid suppressible hyperaldo, adrenal carcinoma
• Clinical:
• May be asymptomatic.
• Headache, weakness, paralysis, polyuria
• Retinopathy, edema uncommon
• Hypokalemia (K normal in 40%), metabolic alkalosis, high-normal Na
15
![Page 16: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/16.jpg)
Screening for Hyper aldosteronism
• Spontaneous hypokalemia (<3.5 mmol/L).
• Profound diuretic-induced hypokalemia (<3.0 mmol/L).
• Hypertension refractory to treatment with 3 or more drugs.
• Incidental adrenal adenomas.
16
![Page 17: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/17.jpg)
17
![Page 18: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/18.jpg)
4. Pheochromocytoma
• Catecholamine-producing neuroendocrine tumor that arises from
chromaffin cells
• Adrenal Medulla : 80-85% pheochromocytomas
• Extra-adrenal paragangliomas
• Often in head and neck (glomus jugulare) and rarely produce catecholamines.
• Some can be dopamine producing.
18
![Page 19: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/19.jpg)
Epidemiology
• Incidence: 1 in 100,000 each year
• Prevalence among pts with HTP
• In adults – 0.1-0.6%
• In children – 1%
• Traditional rule of 10
• 10% bilateral, 10% familial, 10% extra-adrenal, and 10% malignant.
• Recent reports found 12-24% of sporadic pheochromocytoma with germline mutation.
19
![Page 20: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/20.jpg)
Clinical Presentation
• Paroxysmal attacks of Headache, palpitations, and sweating.
• Adults more often have paroxysmal hypertension (50%).
• Children have sustained hypertension (70-90%).
• 20% of children will be normotensive at diagnosis.
20
![Page 21: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/21.jpg)
Pheochromocytoma – Testing
• Best detected during or immediately after episodes
TEST Sensitivity Specificity
Plasma free metanephrine
>0.66nmol/L
99% 89%
24hr urine metanephrine
(>3.7nmol/d)
77% (95%) 93% (96%)
24 urine VMA 64% 95%
21
Lenders, et al. JAMA 2002 Mar 20;287(11):1427-34
![Page 22: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/22.jpg)
Pheochromocytoma - Diagnosis
• Imaging for localization of tumor
TEST Sens Spec PPV NPV
MIBG scintigraphy
(metaiodobenzylguanidine)
78% 100% 100% 87%
CT Scan 98% 70% 69% 98%
MRI 100% 67% 83% 100%
22
Akpunonu, et al. Dis Month.October 1996, p688
![Page 23: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/23.jpg)
5. Cushing’s syndrome
(Hypercortisolism)
• Rare cause of secondary HTN
(0.1- 0.6%)
• Etiology
• Pituitary micro adenoma,
• Iatrogenic (steroid use),
• Ectopic ACTH,
• Adrenal adenoma
• Clinical
• Sudden weight gain, truncal obesity,
moon faces, abdominal striae,
DM/glucose intolerance, HTN, prox
muscle weakness, skin atrophy,
hirsutism /acne
23
![Page 24: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/24.jpg)
Cushings syndrome
24
![Page 25: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/25.jpg)
Cushings syndrome - diagnosis
• Screen: • 24 Hr Urine free cortisol
• >90ug/day is 100% sens and 98% spec
• False + in Polycystic Ovarian Syndrome, depression
• Confirm
• Low dose dexamethasone suppression test
• 1mg dexameth. midnight, measure am plasma cortisol (>100nmol is +)
• Other tests include dexa/CRH suppression test
• Imaging
• CT/MRI head (pit) chest (ectopic ACTH tumor)
25
![Page 26: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/26.jpg)
6. Coarctation of Aorta
• Congenital defect, male>female
• Clinical
• Differential systolic BP arms v/s legs (=DBP)
• May have differential BP in arms if defect is prox to L subclavian art
• Diminished/absent femoral art pulse
• Often asymptomatic
• Echo-Doppler, CT angiography, aortography.
26
![Page 27: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/27.jpg)
Coarctation of Aorta
27
Brickner, et al. NEJM 2000;342:256-263
![Page 28: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/28.jpg)
7. Hyperthyroidism
• 33% of thyrotoxic pt develop HTN
• Usually obvious signs of thyrotoxicosis
• Dx: TSH, Free T4/T3, thyroid
28
![Page 29: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/29.jpg)
8. Hypothyroidism
• 25% hypothyroid patient develop HTN
• Mechanism mediated by local control, as basal metabolism falls so
does accumulation of local metabolites; relative vasoconstriction
ensues
29
![Page 30: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/30.jpg)
30
![Page 31: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/31.jpg)
31
![Page 32: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/32.jpg)
Summary
• Screening for 2ry HTN can be expensive and requires clinical suspicion and knowledge of limitations of different tests
• General principles:
• New onset HTN if <30 or >50 years of age
• HTN refractory to medical Rx (>3-4 meds)
• Specific clinical/lab features typical for dz :
• Hypokalemia in the absence of diuretic therapy may indicate a state of mineralocorticoid excess
• Excess aldosterone production (Conn’s)
• Excess glucocorticoid production (Cushing’s)
• Excess T3 & T4 (hyperthyroidism)
• Epigastric bruits, differential BP in arms, episodic HTN/flushing/palp.
32
![Page 33: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/33.jpg)
Time for quiz !!
![Page 34: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/34.jpg)
Quiz 1. TRUE or FALSE
1. Renal Parenchymal diseases are the common cause of primary HTN.
2. Hypertension is both cause and consequence of renal parenchymal disease.
3. Renal Parenchymal HTN is only due to disturbances in Na/water balance.
4. Renal Vascular disease usualy cause resistive HTN
34
![Page 35: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/35.jpg)
Quiz 1. TRUE or FALSE
1. Renal Parenchymal diseases are the common cause of primary HTN. FALSE
2. Hypertension is both cause and consequence of renal parenchymal disease. TRUE
3. Renal Parenchymal HTN is only due to disturbances in Na/water balance. FALSE
4. Renal Vascular disease usualy cause resistive HTN. TRUE
35
![Page 36: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/36.jpg)
Quiz 2. All of the following studies are helpful in
diagnosis of Renovascular HTN - EXCEPT
A. Urine pH
B. Doppler renal U/S
C. Captopril renography
D. Magnetic Resonance Angiography
E. Renal Angiography
36
![Page 37: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/37.jpg)
Quiz 2. All of the following studies are helpful in
diagnosis of Renovascular HTN – EXCEPT?
A. Urine pH
B. Doppler renal U/S
C. Captopril renography
D. Magnetic Resonance Angiography
E. Renal Angiography
37
![Page 38: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/38.jpg)
Quiz 3. Which of the following statement is not true
about Primary Aldosteronism?
A. May be asymptomatic.
B. Can cause headache, weakness, paralysis, and polyuria.
C. Retinopathy, edema are common finding.
D. Can cause hypokalemia, metabolic alkalosis and high-normal Na.
38
![Page 39: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/39.jpg)
Quiz 3. Which of the following statement is not true
about Primary Aldosteronism?
A. May be asymptomatic.
B. Can cause headache, weakness, paralysis, and polyuria.
C. Retinopathy, edema are common finding.
D. Can cause hypokalemia, metabolic alkalosis and high-normal Na.
39
![Page 40: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/40.jpg)
Quiz 4. Which of the following in NOT true about
Pheochromocytoma?
A. Clinical presentation includes paroxysmal attacks of headache,
palpitations, and sweating.
B. Adults more often have paroxysmal hypertension.
C. Children have sustained hypertension.
D. Majority of children could be normotensive at diagnosis.
E. MIBG scintigraphy (metaiodobenzylguanidine) is diagnostic study
for Pheochromocytoma
40
![Page 41: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/41.jpg)
Quiz 4. Which of the following in NOT true about
Pheochromocytoma?
A. Clinical presentation includes paroxysmal attacks of headache,
palpitations, and sweating.
B. Adults more often have paroxysmal hypertension.
C. Children have sustained hypertension.
D. Majority of children could be normotensive at diagnosis.
E. MIBG scintigraphy (metaiodobenzylguanidine) is diagnostic study
for Pheochromocytoma
41
![Page 42: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/42.jpg)
Quiz 5. Which of the following statement is FALSE
about Coarctation of Aorta?
A. Mostly present as Congenital defect
B. More common in male than female
C. BP in lower extremity is lower than upper extremity
D. Often symptomatic
E. Echo-Doppler, CT angiography, aortography.
42
![Page 43: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/43.jpg)
Quiz 5. Which of the following statement is FALSE
about Coarctation of Aorta?
A. Mostly present as Congenital defect
B. More common in male than female
C. BP in lower extremity is lower than upper extremity
D. Often symptomatic
E. Echo-Doppler, CT angiography, aortography.
43
![Page 44: Hypertension evaluation 2](https://reader030.vdocuments.site/reader030/viewer/2022020307/55ce4e62bb61eb52528b46a1/html5/thumbnails/44.jpg)
Mohammad Ilyas MD, FAAP 44